Minervax ApS logo

Minervax ApS

MinervaX is pursuing the development of a novel vaccine candidate against Group B Streptococci (GBS).

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://minervax.com
Founded2010
Disease Focus
Development Stage
STOCK CODENon Listed
Address
Ole Maaløes Vej 3 DK-2200
Copenhagen N
Netherlands
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://in.linkedin.com/company/minervax-aps” connections=”true” suffix=””]